Scott Reid

PhD Student

University of Strathclyde

Scott is a Biopharmaceutics PhD student utilising the TIM-1 apparatus as an advanced biorelevant dissolution system to predict maximum absorbable dose and how this can inform crystallisation strategy.

Scott graduated with a first-class BSc(Hons) Pharmacology where he specialised in regenerative medicine. He was awarded a vacation scholarship grant where investigated mechanisms of delayed wound closure in diabetes to seek out novel therapeutic targets. He has interned in the US at the NIH clinical centre where he worked on translational biobehavioural studies as well as clinical trials in oncology. Scott joined CMAC in 2024 as a PhD student within the CEDAR CDT.